Back to Journals » Infection and Drug Resistance » Volume 13

Ribaxamase, an Orally Administered β-Lactamase, Diminishes Changes to Acquired Antimicrobial Resistance of the Gut Resistome in Patients Treated with Ceftriaxone

Total article views   HTML views PDF downloads Totals
6,990 Dovepress* 5,694+ 906 6,600
PubMed Central* 1,296 157 1,453
Totals 6,990 1,063 8,053
*Since 22 July 2020
Total mentioned Facebook Delicious Reddit Twitter Others
10 0 0 0 4 6

View citations on PubMed Central and Google Scholar